Natalie Kuldell, President, Founder, & Executive Director, BioBuilder Educational Foundation
Alan Kriz - Open Innovation and Investment
Panel discussion
What are the latest advances in energy innovation?
· The here and now: Where are we today? What new tech tools and approaches are available? What are the most successful energy startups from MIT doing at the moment and why?
· What’s on the near horizon? What new applications are opening up? What are the investment opportunities? What is the smart money focused on? What are corporate priorities in seeking novel energy tech? What does the new energy innovation ecosystem look like (infrastructure, interoperability, technology, use cases, stakeholders, success stories)?
· The future: What advances will we see over the next few years? What's in it for consumers? What are you personally the most excited about?
Panelists:
· Kalyan Veeramachaneni, Principal Research Scientist, MIT Laboratory for Information and Decision Systems
· Dave Truch, Technology Director, Digital Innovation Organization, BP
· Ben Sampson, Director, Energy, GE Ventures
· Tor Jakob Ramsoy, CEO & Founder, Arundo
Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Synthetic Biology Workshop 2017 - Panel Discussion
Max Kanter, Cofounder & CEO, Feature Labs
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Natalya Baily, CEO & Cofounder, Accion